Compare CYTK & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | SEE |
|---|---|---|
| Founded | 1997 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.2B |
| IPO Year | 2004 | 1996 |
| Metric | CYTK | SEE |
|---|---|---|
| Price | $60.52 | $41.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $87.56 | $43.50 |
| AVG Volume (30 Days) | 1.7M | ★ 2.3M |
| Earning Date | 05-25-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | N/A | ★ 89.50 |
| EPS | N/A | ★ 3.43 |
| Revenue | $13,368,000.00 | ★ $5,359,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $302.66 | $2.10 |
| P/E Ratio | ★ N/A | $12.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.31 | $22.78 |
| 52 Week High | $70.98 | $44.27 |
| Indicator | CYTK | SEE |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 49.10 |
| Support Level | $59.25 | $41.79 |
| Resistance Level | $65.93 | $42.04 |
| Average True Range (ATR) | 2.76 | 0.08 |
| MACD | -0.35 | -0.02 |
| Stochastic Oscillator | 18.21 | 30.36 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Sealed Air Corp is a provider of packaging solutions that integrate sustainable, high-performance materials, automation, equipment, and services. The company designs, manufactures, and delivers packaging solutions that preserve food, protect goods, and automate packaging processes. It delivers its packaging solutions to an array of end markets including fresh proteins, foods, fluids and liquids, medical and life science, e-commerce retail, logistics and omnichannel fulfillment operations, and industrials. It has two reportable segments, Food and Protective. The company generates majority of its revenue from the food segment.